NCT06529198尚未招募不适用
The NEUROGYN-GNS Pivotal Clinical Study to Assess the Safety and Efficacy of the Neurogyn Genital Neuromodulation System, a Genital Nerves Neuromodulation Device Used to Treat Idiopathic Overactive Bladder (iOAB).
Prof. Dr. med. Marc Possover0 个研究点目标入组 150 人开始时间: 2025年8月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
- 主要终点
- Reduction in Symptoms greater than or equal to 50%
研究概览
简要总结
The NeuroGyn study is designed to evaluate the safety and effectiveness to the NeuroGyn Genital Neuromodulation System as an aid in the treatment of the symptoms of idiopathic overactive bladder in patients who have failed or could not tolerate more conservative treatments.
详细描述
not provided
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age and older (adult and older adult, all sexes)
- •Diagnosed (urodynamic testing) with idiopathic overactive bladder (iOAB)
- •Symptoms of urinary urgency, frequency, and/or urge incontinence for at least 6 months
- •Failed conservative treatments (e.g., lifestyle modifications, medications)
- •Willing and capable of providing informed consent
- •Capable of participating in all testing associated with this clinical investigation
- •Patients have already undergo a successful GNS-test phase with adhesive electrodes (reduction symptoms greater equal or more than 50%)
排除标准
- •History of pelvic surgery affecting the pubic bone or genital nerves
- •Current urinary tract infection
- •Neurological conditions affecting bladder function (neurogenic OAB)
- •Pregnancy or planning to become pregnant during the study period
- •Contraindications to local anesthesia or surgery
- •Female patients with significant prolapse (i.e., prolapse beyond the introitus).
- •Patients with primary stress incontinence and primary pelvic pain symptoms.
- •Patients with less than 12 months from last intravesical botulinum toxin A therapy
- •Patients with mechanical infravesical obstruction and/or Interstitial Cystitis.
- •Vulnerable patients with co-morbid conditions should be excluded from this study. These co-morbid conditions include all pathologies of the cardiovascular system (Angina Pectoris, Infarct, Thrombose, Embolie, Hypertonia), pulmonary system (asthma, COPD, chr. Bronchitis), intestinal system (morbus Crohn, diverticulitis..) and any malignant disease. These co-morbid conditions also include neurologic diseases (i.e., stroke, multiple sclerosis, spinal cord injury), sacral dermal pathological conditions, congenital or other anatomical sacral anomalies (e.g. spina bifida, sacral agenesis, trauma sequelae), mobility deficits, medically complicated/uncontrolled diabetes, fecal motility disorders (fecal incontinence/constipation), chronic pelvic pain, history of recurrent urinary tract infections (UTIs), gross hematuria, prior pelvic/vaginal surgeries (incontinence/prolapse surgeries), pelvic cancer (bladder, colon, cervix, uterus, prostate), deeply infiltrating endometriosis of the pelvic plexus, sacral plexus or of the bladder, Reiter´s syndrome, and pelvic radiation.
- •Patients suffering from other CNS disorders (mental disorders, severe psychological problems, cerebrovascular accident less than 6 months ago).
- •Patients suffering from polydipsia/polyuria are excluded from the study. Similarly, patients suffering from diabetes insipidus (DI) and diabetes mellitus (DM) are also excluded from the study.
- •A female with a positive urine pregnancy test
- •A female who is breastfeeding
- •Allergies again local anesthesia (Lidocain), Tranquillizers and Antibiotics
研究组 & 干预措施
treatment
Experimental
Patient are undergoing neuromodulatioon
干预措施: NeuroGyn Genital Neuromodulation System (Device)
结局指标
主要结局
Reduction in Symptoms greater than or equal to 50%
时间窗: 6 months - 1 year - 2 years follow up
Overactive Bladder Symptom Score - OABSS
Urodynamic testing
时间窗: 6 months - 1 year - 2 years
Noninvasive uroflowmetry, followed by invasive cystometry and a pressure-flow study + concurrent electromyography (EMG) of pelvic floor muscles and urethral pressure profiles
次要结局
- International Consultation on Incontinence Questionnaire(6 months - 1 year - 2 years)
- The PHQ-9 (Patient Health Questionnaire-9)(6 months - 1 year - 2 years)
研究者
Prof. Dr. med. Marc Possover
PhD MD
Possover International Medical Center AG
相似试验
招募中
不适用
A prospective study to evaluate clinical, neurophysiological and neuropsychological consequences of epilepsy surgery in patients with symptomatic focal epilepsy refractory to pharmacotherapyG40.2Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizuresDRKS00021602niversitätsklinikum Göttingen Klinik für Anästhesiologie und Klinik für Neurologie25
已完成
不适用
Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)Chronic RhinitisNCT05591989Neurent Medical80
已完成
不适用
Evaluating the Efficacy of Artificial Intelligence-based Computer Aided Diagnosis Software That Assists in Determining Whether or Not to Conduct Amyloid PET for the Diagnosis of Alzheimer's Disease by Predicting Amyloid PET Positivity in Mild Cognitive Impairment PatientsAlzheimer DiseaseMild Cognitive ImpairmentNCT05383053Neurozen Inc.227
已完成
不适用
Safety and Efficacy Vagal Nerve Stimulation in Patients With Rheumatoid ArthritisRheumatoid ArthritisNCT01552941SetPoint Medical Corporation18
招募中
不适用
Sequential Genicular Nerve Ablation Prior to Geniculate Artery Embolization in Knee PainChronic Knee PainOsteoarthritisNCT06514755Zagazig University60